Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

The SGLT2 inhibitor empagliflozin (Jardiance) showed some potential for heart failure (HF) prevention in high-risk, ...

If you have hypertrophic cardiomyopathy (HCM) and are experiencing symptoms such as shortness of breath, chest pain, ...

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting ...

Rapid weight loss can increase gallstone formation, and hospitalists have reported more cases of biliary colic and ...

At the 44th Annual JP Morgan Healthcare conference 2026, Eli Lilly highlighted lepodisiran and muvalaplin as the key drugs in ...

Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of cancer treatment for more than ...

The Emirates Drug Establishment (EDE) announced that it has authorised Inpefa (sotagliflozin), an innovative treatment for ...

Dubai, UAE: The Emirates Drug Establishment (EDE) announced that it has authorized Inpefa® (sotagliflozin), an innovative ...

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to ...

The American College of Cardiology found uneven gains and sobering declines in heart health. "You can't treat your way out of ...

FDA-cleared AI-CVD® extracts preventive insights from routine CT—identifying hidden cardiovascular, metabolic, and ...